NR5A2 and focal segmental glomerulosclerosis: In order to identify podocyte proteins that could perform as a similar or better biomarker for the presence of CPF(s), or are involved in the mechanism of action of CPF(s), we here followed a proteomics approach by analyzing proteomes of hPod exposed to presumably CPF-containing plasmas from patients with FSGS.